Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics

This study has been completed.
Sponsor:
Collaborator:
Health Canada
Information provided by:
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00252395
First received: November 9, 2005
Last updated: NA
Last verified: November 2005
History: No changes posted
  Purpose

All reliably evaluated POE systems to date have been desktop computer based, but now there is widespread use and acceptance among physicians of PDA devices for a variety of purposes. Clinicians report that drug information on a PDA improved their access to information and efficiency while reducing their self perceived error rates6. The use of these devices for information retrieval in clinical settings is expected to grow as wireless communication becomes more ubiquitous and as more applications become available6,7. During the past decade there has been a growing awareness of several issues aimed at promoting safer health care for our patients – point of care information technology is one of the keys.

To this end we have worked with a Canadian company, Drugmagnet, to develop and implement PDA-based electronic prescribing system within a major Canadian academic health centre. This is a cluster randomised trial, in which access to and use of the e-prescribing system is switched on and off for randomly chosen weeks, thus time serves as the randomized element.


Condition Intervention Phase
Electronic Prescribing
Device: PDA-based Electronic Prescribing Software
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Effects of Electronic Prescribing on Safety and Quality in Hospital-Based Ambulatory Are: a Randomised Controlled Trial

Resource links provided by NLM:


Further study details as provided by Sunnybrook Health Sciences Centre:

Primary Outcome Measures:
  • Total prescribing error, as measured by the number of call backs received from pharmacists.

Secondary Outcome Measures:
  • a) Interactions
  • b) Dosing and route of administration errors
  • c) Pack errors
  • d) Legibility errors

Estimated Enrollment: 40
Study Start Date: August 2005
Estimated Study Completion Date: August 2006
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • active staff physician at Sunnybrook & Women's College HSC

Exclusion Criteria:

  • inadequate prescribing practice (minimum number)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00252395

Locations
Canada, Ontario
Sunnybrook & Women's College Health Science Centre
Toronto, Ontario, Canada, M4N 3M5
Sponsors and Collaborators
Sunnybrook Health Sciences Centre
Health Canada
Investigators
Study Director: Merrick F Zwarenstein, MBBCH Institute for Clinical Evaluative Science
Principal Investigator: William J Sibbald, MD, MPH Sunnybrook & Women's College Health Sciences Centre
  More Information

No publications provided by Sunnybrook Health Sciences Centre

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00252395     History of Changes
Other Study ID Numbers: S&W e-RX, 6804-15-2003/5590024
Study First Received: November 9, 2005
Last Updated: November 9, 2005
Health Authority: Canada: Health Canada

Keywords provided by Sunnybrook Health Sciences Centre:
medication error
electronic prescribing
patient safety

ClinicalTrials.gov processed this record on September 16, 2014